JUL 24, 2015 11:23 AM PDT

Alzheimer's Attacks Early

WRITTEN BY: Ilene Schneider
An Alzheimer's disease diagnosis is always a sad story. It is that much more so for people in their 30s, just starting their lives, families and careers, replete with expectations and obligations. Now some of the people affected with the disease are taking part in a research program to help others.
Because of a genetic mutation, some people start showing signs of Alzheimer's in their 30s.
A recent piece by Jon Hamilton on NPR told the story of 37-year-old Giedre Cohen, a "young, healthy, beautiful" woman just starting her life until her mind starting wasting away, according to her husband, Tal Cohen, a Los Angeles real estate developer. She and her sister "have a rare gene mutation that causes symptoms of Alzheimer's to appear before they turn 60" (http://www.npr.org/sections/health-shots/2015/07/23/425320514/younger-adults-with-alzheimer-s-are-key-to-drug-search?utm_source=facebook.com&utm_medium=social&utm_campaign=npr&utm_term=nprnews&utm_content=20150723).

According to About.com, as symptoms of dementia occur before the age of 65 - even as early as the mid-thirties -- younger people with dementia have some very specific issues. Most will be employed with financial commitments such as mortgages. They may have young families, probably be fit and active and will struggle to find help for early onset dementia (http://alzheimers.about.com/od/typesofdementia/a/Young_Dementia.htm).

The Cohens are using their experience to help others. A project called DIAN TU is enabling them, along with others in the same situation, to take part in a study of experimental Alzheimer's drugs. According to the NPR story, the project could have enormous benefit for society. As Dr. Randall Bateman, a professor of neurology at Washington University in St. Louis, says, "It's highly likely," he says, that the first drug able to prevent or delay Alzheimer's will emerge from studies of people genetically destined to get the disease. DIAN, the Dominantly Inherited Alzheimer Network, an international research project, is based at Washington University. The "TU" stands for Trials Unit to help participants get access to experimental drugs as part of clinical trials.

Initially, DIAN studied participants to learn more about Alzheimer's, but it created DIAN TU when prospective drugs for Alzheimer's were available for testing in people. Currently, the group includes drug companies, the National Institute on Aging, the Alzheimer's Association and more than 400 members of families with the mutation. When drug companies started to look at ways to prevent Alzheimer's a few years ago, DIAN TU gave them a perfect avenue to reach people with few or no symptoms but the likelihood of developing the disease. People with the mutation are highly likely to develop Alzheimer's around the same age that one of their parents did. The mutation is likely to show up in their siblings as well.

Thus far, the DIAN TU study has tested two different drugs intended to reduce amyloid, the sticky complex protein that accumulates up in the brains of people with Alzheimer's. Currently, 75 percent of the participants are getting one of the candidate drugs, while 25 percent are getting a placebo. They await definitive results for the drugs.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
FEB 26, 2020
Neuroscience
FEB 26, 2020
Why Alzheimer's may be a Sleep Disorder
Alzheimer’s disease is a form of dementia in which amyloid-beta protein builds up in the brain, killing off surrou ...
MAR 04, 2020
Neuroscience
MAR 04, 2020
Memories Are Stored As Specific Neural Firing Patterns
Scientists working on the EPFL Blue Brain Project explain the algebraic patterns of neuron activity.  Scientists at ...
MAR 29, 2020
Cell & Molecular Biology
MAR 29, 2020
Investigating How Genetic Variants Impact the Cerebral Cortex
The outermost layer of the brain is called the cerebral cortex, a relatively thin sheet of gray matter that performs a v ...
APR 26, 2020
Plants & Animals
APR 26, 2020
Researchers Observe Vocal Learning in Bats
Bats have garnered oodles of attention in previous weeks as they’ve been identified as potential carriers of the i ...
APR 26, 2020
Neuroscience
APR 26, 2020
Can you Get PTSD from the COVID-19 Pandemic?
Following a traumatic experience, some experience intense flashbacks, nightmares, irritability, anger and fear. Key symp ...
MAY 11, 2020
Cell & Molecular Biology
MAY 11, 2020
3D Cell Culture Model Suggests Herpes Can Cause Alzheimer's
Alzheimer's is a common form of dementia that affects as many as 5.5 million Americans and the incidence is increasing a ...
Loading Comments...